2025 annual financial data
Rapport Therapeutics 2025 Operating margin
Rapport Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -125,099,000 USD and net income was -111,483,000 USD.
Operating cash flow was -87,473,000 USD.
Get free Rapport Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -125,099,000 USD
- Net income
- -111,483,000 USD
- Operating cash flow
- -87,473,000 USD